Evidence map›Paper›PMID 41466166›Full record

ArticleJournal of thrombosis and thrombolysis2026

Implementing anticoagulation stewardship: the use of a dedicated mobile phone 'app' in the experience of the Italian Federation of Anticoagulation linics (FCSA).

Daniela Poli, Paolo Bucciarelli, Chiara Cappugi, Marco Paolo Donadini, Vittorio Pengo, Giuseppe Rescigno, Luca Sarti, Sophie Testa, Vincenzo Toschi, Alessandro Squizzato

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of thrombosis and thrombolysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Daniela PoliThrombosis Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy. polida@aou-careggi.toscana.it.
Paolo BucciarelliAngelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Chiara CappugiDepartment of Internal Medicine, Ospedale San Giovanni di Dio, Florence, Italy.
Marco Paolo DonadiniCentro di Ricerche per le Malattie Tromboemboliche e le terapia antitrombotiche, Università dell'Insubria e SSD Centro Trombosi e TAO ASST Sette Laghi, Varese, Italy.
Vittorio PengoCardio-Immunology and Thrombosis Research Laboratory, University of Padova, Padua, Italy.
Giuseppe RescignoHaemostasis and Thrombosis Center, DEA P.O. "Umberto I," Nocera Inferiore, Salerno, Italy.
Luca SartiThrombosis Center, Medicina Interna d'Urgenza, Ospedale Civile Baggiovara, Modena, Italy.
Sophie TestaHaemostasis and Thrombosis Centre, Laboratory Medicine Department, ASST Cremona, Cremona, Italy.
Vincenzo ToschiDepartment of Internal Medicine, Casa di Cura Igea, Milan, Italy.
Alessandro SquizzatoResearch Center On Thromboembolic Disorders and Antithrombotic Therapies, University of Insubria, Como, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anticoagulants are life-saving drugs used to prevent and treat thrombosis, and a wide use of these drugs is increasing overtime. However, anticoagulants are one of the most common causes of drug-related adverse events in- and out-of-hospital. The need for empowering clinicians and patients, enhancing compliance and favoring multidisciplinary collaboration, has been widely outlined. Programs of Anticoagulation Stewardship (ACS) have been implemented worldwide. It has been widely demonstrated that ACS is associated with reduction of hospital-acquired blood clots, drug-drug interactions, bleeding events, hospital readmissions, length of hospital stay and other healthcare costs. Although ACS is widely discussed, no ACS model has been extensively and officially realized in the Italian healthcare system. Since its constitution, the Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (i.e. FCSA) supported healthcare professionals providing educational programs, aimed to improve anticoagulation quality and to decrease associated risks and costs. In 2021, FCSA developed an app for mobile phones named FCSApp, which was distributed to affiliated physicians. Aim of this study is to describe this experience. FCSApp was actively used for three years by 100 of 232 registered users, with approximately 3200 messages. The channels of main interest were the so-called 'Clinical Cases' with 1671 messages [52.3%]), and 'Laboratory' (with 586 messages [18.3%]). This experience should be considered in the organization of more comprehensive ACS programs for each national or regional healthcare system.

Indexed as

AnticoagulantsMobile ApplicationsDigital HealthDrug-Related Side Effects and Adverse ReactionsHumansItalyQuality Assurance, Health CareSmartphoneSocieties, MedicalThrombosisAnticoagulantsAnticoagulantsAnticoagulation stewardshipAppMobile phone

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.